Page last updated: 2024-10-24

cefuroxime and Day Blindness

cefuroxime has been researched along with Day Blindness in 2 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"Infectious keratitis is one of the most commonly reported complications in recent years."1.91Multi-drug resistant Klebsiella-induced corneal ulcer following pterygium surgery: a case report. ( Calisir, K; Mohamed, HM; Yussuf, AA, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Calisir, K1
Mohamed, HM1
Yussuf, AA1
Parvizi, N1
Choudhury, N1
Singh, A1

Other Studies

2 other studies available for cefuroxime and Day Blindness

ArticleYear
Multi-drug resistant Klebsiella-induced corneal ulcer following pterygium surgery: a case report.
    BMC ophthalmology, 2023, Apr-24, Volume: 23, Issue:1

    Topics: Cefuroxime; Corneal Ulcer; Female; Humans; Keratitis; Klebsiella; Middle Aged; Pterygium; Vision Dis

2023
Complicated periorbital cellulitis: case report and literature review.
    The Journal of laryngology and otology, 2012, Volume: 126, Issue:1

    Topics: Abscess; Adolescent; Anti-Infective Agents; Cefuroxime; Contrast Media; Decompression, Surgical; Dra

2012